HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers
2020 · Cancer Discovery · 279 citations
https://doi.org/10.1158/2159-8290.cd-20-0215
G
Gregory Weitsman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
143
Papers
1.7K
Citations
22
h-index
31
i10-index
Gregory Weitsman is an academic researcher from King's College London. The author has contributed to research in topics: Neuroblastoma Research and Treatments & HER2/EGFR in Cancer Research & PI3K/AKT/mTOR signaling in cancer. The author has an h-index of 22, co-authored 122 publications.
ORCID: 0000-0002-1313-6279Papers by this author
worksALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation
2018 · Cell Reports · 142 citations
https://doi.org/10.1016/j.celrep.2018.06.066
Estrogen Receptor-α Phosphorylated at Ser118 Is Present at the Promoters of Estrogen-Regulated Genes and Is Not Altered Due to HER-2 Overexpression
2006 · Cancer Research · 77 citations
https://doi.org/10.1158/0008-5472.can-05-4111
Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface
2018 · eLife · 72 citations
https://doi.org/10.7554/elife.32271
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
2022 · Cell Death and Disease · 30 citations
https://doi.org/10.1038/s41419-022-04701-3
Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha
2008 · Breast Cancer Research and Treatment · 26 citations
https://doi.org/10.1007/s10549-008-0221-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat